Top Story

Safety concerns common reason for hepatitis B vaccine refusal

October 24, 2014

SAN DIEGO — Safety and uncertainty involving the risk for hepatitis B are reasons for barriers to vaccine uptake, according to recent study findings presented at the 2014 AAP National Conference and Exhibition.

“Universal hepatitis B vaccination is recommended beginning in the immediate post-natal period,” Bronwyn Baz, MD, of Oregon Health and Science University, wrote in the abstract. “Refusal remains a barrier to universal inoculation. Studying the qualities of groups refusing vaccines, including hepatitis B, may be helpful in identifying strategies for uptake improvement. We assessed uptake of the newborn hepatitis vaccine … with the goal of assessing reasons for refusal and identifying potential interventions.”

FDA News

FDA to review pediatric hexavalent vaccine

October 21, 2014
The FDA has accepted for review a Biologics License Application filed by Merck and Sanofi Pasteur for a pediatric hexavalent combination vaccine containing DTaP…
figure

NIH awards seven research grants for vaccine adjuvants

October 18, 2014
The National Institute of Allergy and Infectious Diseases, a division of the NIH, has awarded seven research grants to separate institutions to explore and develop new…

$5.8 million contract awarded for development of third Ebola vaccine

October 17, 2014
The US Department of Health and Human Services announced a $5.8 million contract toward the development of a third Ebola vaccine, according to a press release.The…
More News Headlines »